Hemorrhagic cystitis in women: epidemiology, etiology, pathogenesis, diagnosis

Cover Page

Cite item

Full Text

Abstract

Hemorrhagic cystitis (HC) in the structure of inflammatory diseases of the lower urinary tract occupies from 5 to 10%, and recently there has been a tendency to increase the number of patients with this disease. HC may be a complication of antitumor chemo - or radiation therapy in patients with malignant tumors of the pelvic organs. However, the most common HC occurs in women with chronic herpes-viral infection. Given the variety of etiological factors leading to the onset of HC, various pathophysiological mechanisms of the disease development take place, which requires an individual approach, the development of examination algorithms and the management of these patients. The article includes a review of foreign and domestic scientific publications on the epidemiology, etiology, pathogenesis and diagnosis of HC.

About the authors

O. B Loran

Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

Email: olegloran@gmail.com
акад. РАН, д-р мед. наук, проф., зав. каф. урологии и хирургической андрологии ФГБОУ ДПО РМАНПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1

L. A Sinyakova

Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

Email: l.a.sinyakova@mail.ru
д-р мед. наук, проф. каф. урологии и хирургической андрологии ФГБОУ ДПО РМАНПО, врач-уролог высшей категории 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1

Ya. I Nezovibatko

Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

Email: post.jacob@gmail.com
аспирант, ст. лаборант каф. урологии и хирургической андрологии ФГБОУ ДПО РМАНПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1

References

  1. Haldar S, Dru C, Bhowmick N.A. Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol 2014; 2 (3): 199-208.
  2. Manikandan R, Kumar S, Lalgudi N. Dorairajan, Hemorrhagic cystitis: A challenge to the urologist. Indian J Urol 2010; 26 (2): 159-66.
  3. Basler J, Kim E. Hemorrhagic Cystitis. Medscape, 2016.
  4. Crew J.P, Jephcott C.R, Reynard J.M. Radiation - induced haemorrhagic cystitis. Eur Urol 2001; 40 (2): 111-23.
  5. Chong K.T, Hampson N.B, Corman J.M. Early hyperbaric therapy improves outcome for radiation - induced hemorrhagic cystitis. Urology 2005; 65: 649-53.
  6. Liem X, Saad F, Delouya G. A Practical Approach to the Management of Radiation - Induced Hemorrhagic Cystitis. Drugs 2015; 75 (13): 1471-82.
  7. Boyle P, Levin B. World cancer report. Lyon: IARC Press, 2008.
  8. Denton A.S, Clarke N, Maher J. Non - surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev 2002; CD001773.
  9. Levenback C, Eifel P.J, Burke T.W et al. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol 1994; 55 (2): 206-10.
  10. Palou J, Pisano F, Esquena S et al. Natural history and predictive factors for hospitalization in patients with radiation cystitis. Results from a large retrospective study. J Urol 2016; 195 (Suppl. 4): e956-e957.
  11. Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 2007; 23: 303-12.
  12. Islam R, Issacson B.J, Zickerman P.M et al. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: Case report. Am J Clin Oncol 2002; 25: 513-4.
  13. Marx C.M, Alpert S.E. Ticarcillin - induced cystitis. Cross reactivity with related pencillin. Am J Dis Child 1984; 138: 670-2.
  14. Andriole G.L, Brickman C, Lack E.E et al. Danazol - induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. J Urol 1986; 135 (1): 44-6.
  15. Naber K.G et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54 (5): 1164-75.
  16. Naber K, Scaeffer A, Heyns C et al. Urogenital Infections. 2010.
  17. Erard V, Storer B, Corey L et al. BK virus infection in haematopoietic stem cell transplant receipents: Frequency, risk factors and association with post engraftment haemorrhagic cystitis. Clin Infect Dis 2004; 39: 1861-5.
  18. Azzi A, Ciappi S, De Santis R et al. Hemorrhagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia. Am J Hematol 1996; 52 (2): 121-2.
  19. Azzi A, Fanci R, Bosi A et al. Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. Bone Marrow Transplant 1994; 14 (2): 235-40.
  20. Bedi A, Miller C.B, Hanson J.L et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13 (5): 1103-9.
  21. Erard V, Kim H.W, Corey L et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106 (3): 1130-2.
  22. Giraud G, Bogdanovic G, Priftakis P et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006; 91 (3): 401-4.
  23. Mylonakis E, Goes N, Rubin R.H et al. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 2001; 72 (10): 1587-92.
  24. Mori Y, Miyamoto T, Kato K et al. Different risk factors related to adenovirus or BK virus - associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011; 31.
  25. Haines H.L, Laskin B.L, Goebel J et al. Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17 (10): 1512-9.
  26. Hoffman J.A, Shah A.J, Ross L.A, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7 (7): 388-94.
  27. Hofland C.A, Eron L.J, Washecka R.M. Hemorrhagic adenovirus cystitis after renal transplantation. Transplant Proc 2004; 36 (10): 3025-7.
  28. Ison M.G. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43 (3): 331-9.
  29. Spach D.H, Bauwens J.E, Myerson D et al. Cytomegalovirus - induced hemorrhagic cystitis following bone marrow transplantation. Clin Infect Dis 1993; 16 (1): 142-4.
  30. Tutuncuoglu S.O, Yanovich S, Ozdemirli M. CMV-induced hemorrhagic cystitis as a complication of peripheral blood stem cell transplantation: case report. Bone Marrow Transplant 2005; 36 (3): 265-6.
  31. Focosi D, Kast R.E. Hyaluronate and risperidone for hemorrhagic cystitis. Bone Marrow Transplant 2007; 39 (1): 57.
  32. Mc Clanahan C, Grimes M.M, Callaghan E, Stewart J. Hemorrhagic cystitis associated with herpes simplex virus. J Urol 1994; 151 (1): 152-3.
  33. Nguyen M.L, Borochovitz D, Thomas G et al. Hemorrhagic cystitis with herpes simplex virus type 2 in the bladder mucosa. Clin Infect Dis 1992; 14 (3): 767-8.
  34. Uhm J, Hamad N, Michelis F.V et al. The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD. Bone Marrow Transplant 2014; 49 (12).
  35. Lunde L.E, Dasaraju S, Cao Q et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant 2015; 13.
  36. Gorczynska E, Turkiewicz D, Rybka K et al. Incidence, clinical outcome, and management of virus -induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11 (10): 797-804.
  37. Smit S.G, Heyns C.F. Management of radiation cystitis. Nat Rev Urol 2010; 7: 206-14.
  38. Payne H, Adamson A, Bahl A et al. Chemical and radiation induced haemorrhagic cystitis: current treatments and challenges. BJU Int 2013; 112: 885-97.
  39. Corman J.M, Mc Clure D, Pritchett R et al. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003; 169 (6): 2200-2.
  40. Zwaans B.M, Chancellor M.B, Lamb L.E. Modeling and treatment of radiation cystitis. Urology 2015; doi: 10.1016/j.urology.2015.11.001
  41. Schoenike S.E, Dana W.J. Ifosfamide and mesna. Clin Pharm 1990; 9: 179-91.
  42. Ribeiro R.A, Freitas H.C, Campos M.C et al. Tumor necrosis factor - alpha and interleukin-1 beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol 2002; 167: 2229-34.
  43. Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 2007; 23: 303-12.
  44. Gomes T.N, Santos C.C, Souza-Filho M.V et al. Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide - induced hemorrhagic cystitis. Braz J Med Biol Res 1995; 28: 1103-8.
  45. Beckman J.S, Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: 1424-37.
  46. Kimura M, Tomita Y, Morishita H, Takahashi K. Presence of mucosal change in the urinary bladder in non hematuria patients with long - term exposure and/or accumulating high - dose cyclophosohamide. Possible significance of follow - up cystoscopy on preventing development of cyclophosphamide - induced hemorrhagic cystitis. Urol Int 1998; 61: 8-11.
  47. Krane D.M, Levine L.A. Hemorrhagic cystitis. AUA Update Series 1992; XI: Lesson 31.
  48. Амвросьева Т.В., Дедюля К.Л., Поклонская Н.В., Богуш З.Ф. Полиомавирусная инфекция человека: значение в патологии и генодиагностика. Здравоохранение. 2014; 10.
  49. Скрябин Г.Н., Александров В.П., Кореньков Д.Г., Назаров Т.Н. Циститы. Учебн. пособие. СПб., 2006.
  50. Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека. 2011.
  51. Talar-Williams C, Hijazi Y.M, Walther M.M et al. Cyclophosphamide - induced cystitis and bladder cancer in patients with Wegener′s granulomatosis. Ann Intern Med 1996; 124: 477-84.
  52. Droller M.J, Saral R, Santos G. Prevention of cyclophosphamide - induced hemorrhagic cystitis. Urology 1982; 20: 256-8.
  53. Radcliffe K, European STD Guidelines, 2004.
  54. Paduch D.A. Viral lower urinary tract infections. Curr Urol Rep 2007; 8: 324-35.
  55. Zaleska-Dorobisz U, Biel A, Sokołowska-Dąbek D et al. Ultrasonography in the diagnosis of hemorrhagic cystitis - a complication of bone marrow transplantation in pediatric oncology patients. J Ultrason 2014; 14 (58): 258-72.
  56. Epstein J, Reuter V, Amin M. Biopsy Interpretation of the Bladder. 2nd edition, 2011.

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies